Mexico - Delayed Quote MXN
Charles River Laboratories International, Inc. (CRL.MX)
4,066.92
+663.93
+(19.51%)
At close: December 10 at 1:32:31 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 17 | 17 |
| Avg. Estimate | 941.94M | 958.79M | 3.82B | 3.95B |
| Low Estimate | 928.43M | 944.92M | 3.77B | 3.43B |
| High Estimate | 964.9M | 975.8M | 3.88B | 4.1B |
| Year Ago Sales | 1.01B | 1.03B | 4.05B | 3.82B |
| Sales Growth (year/est) | -6.88% | -6.56% | -5.60% | 3.39% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CRL.MX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/10/2025 |
| Maintains | Mizuho: Neutral to Neutral | 4/9/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 3/21/2025 |
| Upgrade | Citigroup: Sell to Neutral | 3/4/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 2/20/2025 |
| Maintains | Baird: Neutral to Neutral | 2/20/2025 |